Meng has found that autophagy inhibitor in combination with VEGFR2 inhibitor Apatinib can further inhibit papillary thyroid carcinoma cell proliferation and induce PARP/Bcl-2-mediated apoptosis [40]. Here, KDR is linked to thyroid gland papillary carcinoma.